+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Potentiation of haloperidol-induced catalepsy by beta-adrenoceptor antagonists in mice



Potentiation of haloperidol-induced catalepsy by beta-adrenoceptor antagonists in mice



Japanese Journal of Pharmacology 42(1): 79-85



Several clinical papers have reported that beta-adrenoceptor antagonists were useful in the management of schizophrenia and tardive dyskinesia. The present study examined effects of beta-antagonists on haloperidol (HAL)-induced catalepsy using mice in order to study the relationship between beta-antagonists and central dopaminergic functions. Catalepsy was tested by the standard bar test 30 min after intraperitoneal treatment of HAL. Beta-antagonists were administered subcutaneously just after HAL-treatment. Propranolol, alprenolol, oxprenolol and pindolol increased the incidence of catalepsy compared to HAL alone. Atenolol, not penetrating into the brain, and the sedative and hypnotic drug chlordiazepoxide did not potentiate it. These results suggest that the potentiation of HAL-catalepsy by beta-antagonists is based on their central action. Therefore, a central beta-receptor appears to be implicated in the regulation of the central dopaminergic functions.

(PDF emailed within 0-6 h: $19.90)

Accession: 041026265

Download citation: RISBibTeXText

PMID: 2879054

DOI: 10.1254/jjp.42.79


Related references

Comparison of quetiapine with other antipsychotic drugs on potentiation of haloperidol-induced catalepsy in mice. Journal of Pharmacological Sciences 91(Supplement I): 196P, 2003

Mirtazapine enhances the effect of haloperidol on apomorphine-induced climbing behaviour in mice and attenuates haloperidol-induced catalepsy in rats. Psychopharmacology. 135(3): 284-289,. 1, 1998

Effect of chronic treatments with nicotine and haloperidol on nicotine potentiation of haloperidol induced catalepsy. Society for Neuroscience Abstracts 17(1-2): 689, 1991

Nicotine potentiation of haloperidol-induced catalepsy: Striatal mechanisms. Pharmacology Biochemistry and Behavior 46(2): 303-307, 1993

Synergistic potentiation of haloperidol induced catalepsy by gamma butyro lactone. Journal of Neurochemistry 27(3): 821-823, 1976

Potentiation of haloperidol-induced catalepsy by dopamine agonists: possible involvement of central 5-hydroxytryptamine. Pharmacology, Biochemistry, and Behavior 10(4): 475-480, 1979

Potentiation of haloperidol-induced catalepsy by ascorbic acid in rats and nonhuman primates. Pharmacology, Biochemistry, and Behavior 24(3): 781-783, 1986

Haloperidol-induced catalepsy is influenced by calcium channel antagonists. Acta Poloniae Pharmaceutica 57(3): 233-237, 2001

Haloperidol-induced catalepsy is influenced by adenosine receptor antagonists. Polish Journal of Pharmacology 49(5): 323-327, 1998

Caffeine and muscarinic antagonists act in synergy to inhibit haloperidol-induced catalepsy. Neuropharmacology 45(4): 493-503, September, 2003

Biphasic effects of direct, but not indirect, GABA mimetics and antagonists on haloperidol-induced catalepsy. Naunyn-Schmiedeberg's Archives of Pharmacology 311(2): 179-184, 1980

The selective dopamine D3 receptor antagonists, SB 277011-A and S 33084 block haloperidol-induced catalepsy in rats. European Journal of Pharmacology 572(2-3): 171-174, 2007

Haloperidol inhibits bicuculline-induced seizures and bicuculline potentiates haloperidol-induced catalepsy in mice. Indian Journal of Pharmacology 31(6): 434-436, 1999

Effect of M3-choline receptor blockade on the ability of muscarinic antagonists to prevent catalepsy induced by haloperidol in rats. Eksperimental'naia i Klinicheskaia Farmakologiia 64(4): 10-12, 2001